Chongqing Boteng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, without false records, misleading statements, or significant omissions.
The Company held the seventh meeting of the sixth board of directors on April 2, 2026, and approved the proposal regarding the application for credit limits from banks for the year 2026. The board agreed that the Company would apply for comprehensive credit from eight banks in 2026, with a total of no more than RMB 2.409 billion and no more than USD 6.4 million. The specific details are as follows: